Management of Uncontrolled Spasm of Left Knee and Thigh
Begin immediately with antispastic positioning, range of motion exercises, and stretching performed several times daily, then escalate to oral baclofen or tizanidine if spasticity causes pain, impairs function, or interferes with positioning. 1
Stepwise Treatment Algorithm
First-Line: Physical Interventions (Start Immediately)
- Antispastic positioning multiple times daily
- Passive stretching and range of motion exercises performed several times daily
- Splinting if contractures are developing or limiting function
- Serial casting for established contractures that restrict joint movement 1
These non-invasive modalities form the foundation of spasticity management and should be implemented before or alongside any pharmacological intervention.
Second-Line: Oral Antispastic Medications
If spasticity results in pain, poor skin hygiene, or decreased function, consider:
- Baclofen (first choice for spinal-origin spasticity) 1
- Tizanidine (specifically effective in chronic stroke patients with demonstrated efficacy for spasticity and pain without loss of motor strength) 1
- Dantrolene (acts directly on muscle tissue; limited trial data but has benefit of no cognitive side effects) 1
Critical caveat: Avoid diazepam and other benzodiazepines - they have deleterious effects on recovery in stroke patients and cause problematic sedation 1
Start medications at low doses and titrate gradually to minimize adverse effects while achieving the lowest effective dose.
Third-Line: Focal Interventions for Refractory Cases
For disabling or painful spasticity unresponsive to oral medications:
- Botulinum toxin injections into affected muscle groups (strong recommendation for focal spasticity that is painful, impairs function, reduces rehabilitation participation, or compromises positioning/skin care) 1, 2, 3
- Phenol/alcohol nerve blocks for selected patients 1
Fourth-Line: Advanced Interventions
For chronic, severe spasticity refractory to above measures:
- Intrathecal baclofen (via surgically implanted pump) - demonstrated efficacy in chronic patients with stroke onset >6 months 1
- Neurosurgical procedures (selective dorsal rhizotomy or dorsal root entry zone lesions) - reserved for refractory cases, but carry significant operative risks including unintended spinal cord damage 1
Key Clinical Considerations
Differentiate the primary problem: Determine whether dysfunction stems from weakness, spasticity, or both through careful physical examination 4, 5. This distinction is critical for treatment selection.
Diagnostic adjuncts that may guide treatment:
- Short-acting nerve blocks (baclofen or carbamazepine may be effective for nerve root-related spasm) 6
- Botulinum toxin diagnostic injections
- Instrumented gait analysis if ambulation is affected 4, 5
Common pitfall: Not all spasticity requires treatment 7. Only treat when it causes pain, functional impairment, skin hygiene problems, or interferes with rehabilitation goals.
Evidence strength: The stroke rehabilitation guidelines 1 provide the most comprehensive framework, though they acknowledge limited controlled trial evidence for spasticity treatment. Most trials show spasticity and pain reduction but minimal functional gains with oral medications. The stepwise approach from least to most invasive remains the standard despite limited comparative data.
Goal-oriented approach: Treatment should target meaningful patient-specific goals - whether improving ambulation, reducing pain, facilitating caregiving, or enabling participation in rehabilitation 2, 7.